Caisse DE Depot ET Placement DU Quebec Boosts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Caisse DE Depot ET Placement DU Quebec raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 46.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 336,339 shares of the medical equipment provider's stock after buying an additional 107,033 shares during the period. Caisse DE Depot ET Placement DU Quebec owned 0.09% of Intuitive Surgical worth $175,556,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical in the fourth quarter worth about $82,517,000. Sycomore Asset Management boosted its stake in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after acquiring an additional 4,079 shares during the last quarter. Exome Asset Management LLC grew its position in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after acquiring an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. increased its stake in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after purchasing an additional 525 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

ISRG has been the subject of a number of recent research reports. Bernstein Bank raised their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday, January 24th. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Finally, Piper Sandler reduced their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $598.95.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 188 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $566.94, for a total transaction of $106,584.72. Following the transaction, the chief financial officer now directly owns 7,162 shares in the company, valued at $4,060,424.28. This trade represents a 2.56 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,313 shares of company stock worth $17,229,143. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $2.32 during trading hours on Tuesday, reaching $529.50. 492,411 shares of the stock traded hands, compared to its average volume of 1,619,980. The stock has a 50 day simple moving average of $503.33 and a two-hundred day simple moving average of $534.46. Intuitive Surgical, Inc. has a 1 year low of $379.67 and a 1 year high of $616.00. The company has a market cap of $189.78 billion, a price-to-earnings ratio of 82.61, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the firm posted $1.50 EPS. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.